West Pharmaceutical Services | WST - Interest Expense On Debt



West Pharmaceutical Services reported $100K in Interest Expense on Debt for its fiscal quarter ending in June of 2025.


Interest Expense On Debt Change Date
Align Technology 0 0 Sep/2024
Avanos Medical USD 2M 100K Jun/2025
Baxter International USD 81M 19M Mar/2025
Becton, Dickinson and Co. USD 152M 1000K Jun/2025
Charles River Laboratories USD 29.97M 2.08M Jun/2025
Cooper Companies USD 25.4M 1.2M Jul/2025
Dentsply International USD 24M 1000K Jun/2025
Haemonetics USD 6.96M 1.36M Sep/2024
ICU Medical USD 23.06M 1.03M Jun/2025
Insulet USD 9.5M 8.3M Jun/2025
Integra LifeSciences USD 21.04M 2.23M Jun/2025
IQVIA Holdings USD 182M 17M Jun/2025
J&J USD 128M 9M Mar/2025
Medtronic USD 176M 2M Jul/2025
Merit Medical Systems USD 6.78M 207K Jun/2025
Neogen USD 16.48M 553K May/2025
Quidel USD 42.9M 600K Jun/2025
Repligen USD 5.35M 104K Jun/2025
Solventum Corp 103M 1000K Jun/2025
STAAR Surgical USD 1000 0 Dec/2024
Terumo 1.28B 1.14B Jun/2025
West Pharmaceutical Services USD 100K 300K Jun/2025